Abstract
The concept of Tropical Disease Priority Review Voucher (PRV) is one of the inventive strategies to influence the pharmaceutical manufacturers to develop drugs for the marginalized population suffering from the neglected diseases. This is an award which is granted upon the successful approval of a medicine developed for the neglected tropical disease. This can be used in turn to accelerate the review procedure of another drug or transfer it to another company. There are advantages, limitations and proposals with respect to the program which have been put forth in this review article. Most of the secondary data was collected from the following sources: the review was carried out by reference to the officially published regulatory directives of the government, academic journals, online journals, market research papers and newspaper articles available from the online library. This literature was compiled using a variety of search engines, e.g. PubMed, Google Scholar, and a lot more.
| Original language | English |
|---|---|
| Pages (from-to) | 24-28 |
| Number of pages | 5 |
| Journal | Pharma Times |
| Volume | 54 |
| Issue number | 11 |
| Publication status | Published - 11-2022 |
All Science Journal Classification (ASJC) codes
- Pharmacology, Toxicology and Pharmaceutics(all)
